Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease

Noninvasive biomarkers are clinically useful for evaluating liver fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD). The aim of the present study was to compare plasma proteins in patients with early nonalcoholic steatohepatitis (NASH) (F0-F1) versus NASH with significant/adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Wei, Janech, Michael G., Sobolesky, Philip M., Bland, Alison M., Samsuddin, Salma, Alazawi, William, Syn, Wing-Kin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Gastrointestinal, Renal & Hepatic Systems
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944676/
https://www.ncbi.nlm.nih.gov/pubmed/31860081
http://dx.doi.org/10.1042/BSR20190395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944676/
https://www.ncbi.nlm.nih.gov/pubmed/31860081
http://dx.doi.org/10.1042/BSR20190395

Ejemplares similares